Feature | Anti-PM/Scl, n (%) | Anti-ARS, n (%) |
---|---|---|
Location | ||
Predominantly subpleural | 3/9 (33) | 4/12 (33) |
Predominantly basal | 8/9 (89) | 12/12 (100) |
Ground-glass attenuation | 8/9 (89) | 11/12 (92) |
Consolidation | 8/9 (89) | 6/12 (50) |
Traction bronchiectasis | 2/9 (22) | 3/12 (25) |
Honeycombing | 0/9 (0) | 1/12 (8) |
Reticular opacity | 6/9 (67) | 10/12 (83) |
Micronodules | 2/9 (22) | 0/12 (0) |
Predominant feature | ||
Reticulation | 6/9 (67) | 9/12 (75) |
Ground-glass attenuation | 2/9 (22) | 2/12 (17) |
Consolidation | 1/9 (11) | 1/12 (8) |